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Abstract
Background: Health sector and programme performance assessments provide a rich source of contextual data
directly linked to implementation of programmes and can inform health policy dialogue, planning and resource
allocation. In seeking to maximise this opportunity, there are challenges to overcome. A meeting convened by the
World Health Organization African Region discussed the strengths, weaknesses and challenges to harmonising and
standardising health sector and programme performance assessments, as well as use of evidence from such
processes in decision making. This article synthesises the deliberations which emerged from the meeting.
Discussing these in light of other literature we propose practical options to standardising health sector and
programme performance assessment and improve realisation of using evidence in decision making.
Discussion: Use of evidence generated from health sector and programme performance assessments into regular
country processes of sectoral monitoring, dialogue and policy modification is crucial. However, this process faces
several challenges. Identified challenges were categorised under several themes, namely the weak institutional
capacities for monitoring and evaluation in reference to weak health information systems, a lack of tools and skills,
and weak accountability mechanisms; desynchronised planning timeframes between programme and overall health
sector strategies; inadequate time to undertake comprehensive and good quality performance assessment; weak
mechanisms for following up on implementation of recommendations; lack of effective stakeholder participation;
and divergent political aspirations.
Conclusion: The question of what performance assessment is for in a country must be asked and answered clearly
if the utility of these processes is to be realised. Standardising programme and sector reviews offers numerable
opportunities that need to be maximised. Identified challenges need to be overcome through strengthened
Ministry of Health leadership, effective stakeholder engagement and institutionalising follow-up mechanisms for
agreed recommendations. In addition, health sector performance assessments need to be institutionalised as part
of the accountability mechanism, and they must be planned for and funding secured within annual budget and
medium term expenditure frameworks.
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Background
Health sector and programme performance assessments
are a rich source of contextual data directly linked to the
implementation of country strategic and operational plans.
Ideally, these assessments should be a good source of evi-
dence to inform decision making, planning and resource
allocation at sub-national and national levels. They should
also inform stakeholder dialogue through joint-review
processes surrounding decision making about allocation
and distribution of human and financial resources, infra-
structure, medicines and technologies. Stakeholders are
herein defined “as actors who have an interest in the issue
under consideration, who are affected by the issue or, who
– because of their positions – have or could have an active
or passive influence on the decision making or implemen-
tation processes” [1]. We adopt the definition of perform-
ance assessment provided by Smith et al. [2] as “seeking to
monitor, evaluate, and communicate the extent to which
key objectives are met”. The process involves collection,
review and use of information for a purpose [3]. Health
sector and programme performance assessments use data
from several sources, including the health management
information system, service availability and readiness as-
sessment, administrative data, national health accounts,
and surveys such as the demographic health surveys and
household living surveys.
The Sixty Fourth World Health Assembly urges mem-
ber states to “regularly monitor, review and adjust their
national or subnational health policies, strategies and
plans with a view to developing evidence-based responses
to evolving challenges and opportunities, and to involve
all relevant stakeholders” [4]. This is intended to lay a
foundation of two prerequisite actions, namely (1) the
regular involvement of stakeholders in performance as-
sessment and (2) the use of evidence in decision-making,
both of which call for engagement of health actors in
policy dialogue. In this article, we adopt the definition of
health policy dialogue by Dheepa et al. [5], as “a dialogue
that is part and parcel of the policy and decision-making
processes, intended to contribute to developing or imple-
menting a policy change following a round of evidence-
based discussions/workshops/consultations on a particular
subject”.
Anecdotal data from country actors indicates multiple
challenges to maximising the relevancy of performance
assessments. These include issues of data quality and
timeliness from routine health information systems,
tensions in the generation of bottom-up evidence and
the propagation of top-down priorities, and conflicting
planning and resource allocation timeframes between
the sector and programmes. While there are reports
detailing lessons from strengthening in-country moni-
toring and evaluation (M&E) systems [6–8], the bulk of
these are written from donor perspectives; the literature
is near-void of documented perspectives from countries
themselves.
Countries develop national health policies and medium-
term (i.e. 3–5 year) sector strategic plans for operationalis-
ing policy aspirations. Strategic plans are implemented
through annual operation plans which are meant to be
aligned to annual budget cycles. Performance assessment
of such plans needs to be undertaken regularly against set
indicators to assess attainment of progress and modify the
input of resources for improved service delivery as neces-
sary. M&E plans are developed to guide health sector
performance assessment. Results emanating from such as-
sessments need to improve evidence-based planning and
decision-making, as well as overall health sector perform-
ance. M&E plans detail the indicators for performance
assessment, data sources to be used, periodicity of report-
ing, institutional strengthening activities, roles of the dif-
ferent actors and how results will inform decision-making
[9]. Vertical programmes (such as malaria, tuberculosis,
and immunisation) develop strategic and operational plans
as well. Such programmatic strategies should be developed
in line with overall sector objectives and strategies and
with synchronised implementation timeframes. In terms
of M&E, core programmatic indicators need to be in-
cluded in the overall M&E plans. While programmes may
maintain their own indicators for more comprehensive
programme assessment, their core indicators must be
aligned with the assessment of the health sector strategic
plan and feed into the overall health sector performance
assessment. In this article, we use the term performance
assessment to denote annual reviews and evaluation of
strategic plans.
Currently in the WHO African Region, all the 47 mem-
ber states have national health strategic plans in place, and
most, 38 out of the 47 countries, have institutionalised
annual health sector reviews and undertake regular evalu-
ation of their strategic plans. A meeting convened by the
WHO Africa Regional Office in December 2015 brought
together M&E country teams (comprised of head of M&E
in the Ministry of Health (MoH) (n = 2 per country)
and M&E technical officers from the WHO country
office (n = 1 per country)) and senior malaria, AIDS,
tuberculosis, reproductive, maternal, newborn, child
and adolescent health, and nutrition technical officers
from WHO. The 36 meeting participants were from ten
countries (Ethiopia, Ghana, Kenya, Lesotho, Liberia,
Malawi, The Gambia, Uganda, Zambia and Zimbabwe).
The 10 countries were selected based on language
(Anglophone, given the fact that the meeting would be
conducted in English) and with the prerequisite of
institutionalised annual health sector reviews and
evaluation of strategic plans. The only country that did
not take part was Tanzania due to government restric-
tions in missions outside the country; however, there
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were no anticipated differences between Tanzania and the
countries that participated. Tanzania, like the other coun-
tries, has had periodic health sector reviews done annu-
ally. There was a general spread over the 10 countries
represented. Although it had been initially intended to
have participation both from the WHO country office and
the MoH, Lesotho, Zambia and Zimbabwe did not have
the MoH representatives while Kenya had only Ministry
and County health officials represented. The persons from
the MoHs were nationals of those particular countries and
to some extent a good number of the WHO Country Of-
fice representatives.
As far as we are aware, this was the first meeting in
the WHO African Region to be convened with the ob-
jective of reviewing and making recommendations for a
harmonised and standardised approach to health sector
and programme reviews and evaluations in order to real-
ise a comprehensive health sector performance assess-
ment, as well as use of evidence in policy dialogue and
decision making. It is expected that there would be op-
portunity for holding such meetings periodically to learn
and improve on undertaking and making use of the sec-
tor reviews. A report of the meeting was produced and
the follow-up actions include using the outcome of the
meeting to inform the development of a harmonised
guide for health sector reviews.
Use of evidence in policy development and decision-
making has gained prominence over the last decade.
Scholars have highlighted facilitating factors as well as
barriers to uptake of evidence. Among the facilitating
factors is the quality and timeliness of the evidence,
credibility of researches, providing practical solutions
and dissemination in digestible forms [10]. However, we
note that much of this literature refers to evidence de-
rived from systematic research processes as opposed to
evidence from routine information systems like health
management information systems. Policymakers in low-
income countries have pointed out the fact that the dif-
ferent types of evidence, both from formal (systematic
research processes and routine information systems) and
informal systems like community complaints do play a
role on policy development [11–13].
Lavis et al. [10] cite four approaches that can be
employed, either singly or in combination, to link research
to action, namely the push efforts by researchers, the pull
efforts by users, the exchange efforts with partnership be-
tween researchers and users, and use of large-scale know-
ledge translation platforms. The health sector reviews of
health sector strategic plans in the African Region have
mainly tried to harness information to respond to issues
pertaining to the performance of the sector towards
agreed targets. Although they can profit from the four ap-
proaches, they have commonly used pull efforts by using
information either from appropriate research or from
other data sources to influence action. Attempts at ex-
change efforts have performed suboptimally due to the
limited participation of researchers in sector reviews, the
large numbers of which are not conducive for effective
dialogue and varied skills among the actors involved [14].
This debate article outlines the deliberations that
emerged from the meeting, identifying the strengths,
weaknesses and challenges to harmonising and standar-
dising health sector and programme performance as-
sessment. By synthesising these discussions and country
and programme experiences, we seek to document and
provide evidence to support the strengthening of the
health sector and programme performance assessments
and as well as country-level M&E, evidenced-based
planning and policy modification. We conclude by pro-
posing practical options to improving the use of evi-
dence from performance assessments in health policy
dialogue and decision-making at all levels of the health
system. The proposed practical solution will further be
incorporated in a guide to “Harmonize and Standardize
Health Sector Reviews and Evaluations in the WHO Af-
rican Region”, which is currently under development.
Findings
Obstacles to relevant performance assessments
The meeting identified several issues as challenges that
currently prevent the full realisation of health sector and
programme assessment utility in country-level planning
cycles. The main themes that emerged were (1) weak
institutional capacities for M&E; (2) desynchronised
planning timeframes between programmes and overall
health sector strategies; (3) inadequate time to undertake
comprehensive and good quality performance assess-
ments; (4) weak mechanisms for follow-up; (5) lack of
effective stakeholder participation; and (6) divergent pol-
itical aspirations. We take each issue in turn.
Weak institutional capacities for M&E
Ensuring good quality evidence from performance assess-
ments calls for adequate institutional capacity for M&E in
terms of strong national health information systems,
availability of tools and skills. Meeting participants noted
that programme M&E activities were regularly better-
resourced and had stronger M&E capacity. Participants
partly attributed this to the increased funding from global
health initiatives (GHIs) and other donor funds, and the
accompanying stringent reporting requirements. Although
GHIs have invested in health system strengthening and
M&E, available evidence showed that investments were
made in specific programme areas rather than within the
health system generally [15]. GHIs have always empha-
sised that it is the responsibility of national authorities
to identify general areas of support [16]. Related to this
was the issue of resources for running annual reviews
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themselves; one country in particular noted that the
lack of funds prevented them from holding annual re-
views for 2 years. In several of the countries present
participants shared that performance assessments were
funded by donors with insignificant financial inputs
from national governments.
Most countries have significant funding from donors
amounting to approximately 40%, especially for programme
operations [17]. However, the data are government data
that would be available and hence should not constitute a
big barrier. Although, in cases where the data is handled
and kept by the organisations, data that may not be in
favour of the organisations’ objectives will not be easy to ac-
cess. Reference to donors in this paper is for the usual bilat-
eral and multilateral donors in most of the countries such
as United Nations agencies, United States Agency for Inter-
national Development, UK Department for International
Development, Swedish International Development Cooper-
ation Agency, The Global Fund against AIDS, Tuberculosis
and Malaria, and PEPFAR, among others.
Performance assessments are routine processes that
must be planned for and funding secured within annual
budgeting processes. The gaps in planning for these
processes may partly explain the inferior quality re-
ported in some countries as well as omissions where
annual reviews are missed. This presents a missed oppor-
tunity for evidence-based dialogue and resource alloca-
tion. Paradoxically, while gaps in data are a problem,
parallels in data collection systems and the multiplicity of
data collection tools and reporting channels is a long-
standing problem, which in turn compromise data quality.
Although performance assessments should serve as
a mechanism of mutual accountability, weak owner-
ship and limited participation of senior level MoH of-
ficers was a matter of concern. This lack of ownership
also translates to policy dialogue processes where,
often, the MoH should be seen as the lead organisa-
tion for vision and coordination, but is not. Such a
state of affairs runs contrary to the principles of the
Paris Declaration, which emphasise country ownership
and mutual accountability [18].
Desynchronised planning timeframes between
programmes and overall health sector strategies
Ensuring that programme performance assessment in-
forms overall sector performance calls for synchronisation
at the planning stage with regards to timeframes of the
strategic and operation plans. In reality, this is not yet the
case in many of the countries. Figure 1 depicts the overlap
and desynchronisation of programme planning cycles in
Kenya
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National malaria strategy
Strategic plan for leprosy TB and lung disease
Uganda
Maternal Health Plan
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HIV/AIDS Plan




Multi-Year Plan (cYMP) for Immunization
National Development Plan


















Fig. 1 Planning cycles for health sector and programme strategic plans. Source: WHO country planning cycle database: http://
www.nationalplanningcycles.org/planning-cycle/. Accessed 25 May 2015
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Kenya, Uganda and Zimbabwe as an illustration. There
is no alignment, with reference to timeframes, between
programme strategic plans and the national health sector
strategic plan. In many countries, the same actors will be
involved across programmes creating burdens of time and
priority. In such instances, reviews and performance as-
sessments are done at different times of the year resulting
in multiplicity of review fora which participants noted as a
hindrance to full stakeholder participation. Suboptimal
discussions given the limited time to internalise the evi-
dence, and contradictory decisions given the lack of a
comprehensive view of sector performance also emerge as
challenges. Additionally, the multiplicity of meeting fora
stretches the already limited M&E capacities. This desyn-
chronisation does not allow for alignment of reviews and
realising a comprehensive health sector performance
assessment.
Inadequate time to undertake comprehensive and good
quality performance assessments
Another issue with timing relates to the time required to
actually undertake annual reviews and evaluations. This
was noted to vary in the different countries between 2
and 4 months in the case of annual reviews and 3 and 6
months in the case of evaluations of health sector strat-
egies. Longer periods impact on the ability to implement
health programmes as staff are drawn away into under-
taking assessments. The issue of undertaking subnational
reviews and pooling findings into the overall review,
coupled with the quest to ensure quality, calls for ad-
equate time.
Use of evidence in decision making is impacted by the
quality of the evidence [4, 5]. The quality of the reviews
varied considerably and some attributed this to the
methodologies employed, capacity of the teams involved
and type of data used. Use of peer learning, looking at
comparable subnational entities as well as countries, was
discussed as one the ways to improve performance. This
is difficult given the different methodologies employed.
On a positive note, however, was the case of Ghana,
where a standardised review guideline was provided to
districts alongside institutionalisation of a mechanism
for cross fertilisation through district participation, pro-
viding room for peer critique and forging joint solutions.
In addition, a holistic tool was developed to guide the
pooling of subnational reviews into the overall health
sector performance assessment. This serves as a best
case scenario that can be emulated by other countries.
Weak mechanisms for follow-up
This was noted as a weakness in several countries. Fre-
quently, implementation of recommendations from re-
views and evaluation was reported as suboptimal by
participants, and many felt that limited dissemination
was one of the main obstacles to overcome. The most
common modality of dissemination was the bulky and
detailed review reports, which are not conducive for
rapid internalisation. However, participants also gave ex-
amples of good practices. For example, in Malawi, the
country develops a matrix for following up on recom-
mendations with a timeframe and responsible officers.
In Ghana and Uganda, an aide memoire between gov-
ernment actors and development partners indicates
agreed upon actions for follow-up and is signed by all
actors as a sign of commitment. One of the elements of
good health policy dialogue is putting in place mecha-
nisms for following up on recommendations [9].
Lack of effective stakeholder participation
Institutionalising multi-sectoral collaboration and strength-
ening partnership frameworks remains a challenge in ensur-
ing effective participation of all actors. Participants referred
to inter-ministry relationships in terms of data sharing as
ad hoc. Additionally, all countries noted that there were no
routine mechanisms for collecting data from private-for-
profit providers, meaning that a significant chunk of data
for planning was excluded. However, in-line with the
principle of mutual accountability, all health actors, includ-
ing civil society, private-for-profit and private-not-for-profit
actors, should all participate in assessing performance. Re-
latedly, there were challenges for donor programmes that
supported implementation either through implementing
partners or direct implementation by themselves. Concerns
raised in this regard were poor sharing of data with the
MoH since the implementing partners were only obliged to
report to the donors. Likewise, donors were only sharing
data with their head offices. A good practice here is the case
of Rwanda, where all civil society organisations involved in
the health sector are obliged to report to government by
law. Such a practice can be emulated by other countries in
a quest to ensure comprehensive performance assessment.
Divergent political aspirations
This was in particular reference to decentralised health
systems, which can further stress M&E systems by the
proliferation of new districts, and also challenge the
effectiveness of annual reviews and evaluations. For ex-
ample, one country cited an example where subnational
politicians disagreed with the review findings despite the
fact that they had no contrary evidence. This further
underlines questions of what indeed ‘evidence-based
planning’ means.
Discussion
Health sector performance assessments are only as use-
ful as their ability to influence decision-making. Feeding
the evidence that gets generated from them into regular
country processes of sectoral monitoring, dialogue and
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policy modification is just a first step [19]. Health sector
and programme performance assessments can provide
rich contextual data that can inform health dialogue,
planning and resource allocation. As such, efforts need
to be made to maximise this opportunity.
This article raises several issues regarding the utility
and relevance of annual reviews and evaluations for
evidence-based health planning, in particular how they
may be more greatly exploited to influence policy dia-
logue processes. There remain technical challenges, such
as weak institutional capacities for M&E at national and
subnational levels and weak data sources that need to be
strengthened according to international standards and in
a systematic way. Perhaps the most pertinent issue is the
role of donor financing and donor priorities which can
skew the focus of routine M&E country functions. The
challenge of vertical programmes being better-resourced
than other health areas is a persistent problem [20, 21].
Similarly, Chan et al. [22] noted that previous attempts
have been fragmented, focussed on single disease informa-
tion needs as opposed to strengthening health information
systems in a systematic way. This raises two points. First,
it requires strengthened governance at national level to
ensure responsive investments of donor funds through
evidence-based negotiation and clear articulation of
locally-driven needs. Secondly, there is a need to share re-
sources within the health sector, inputs such as technical
officers, donor technical assistance and funding can be
used to strengthen sectoral, and not only programmatic,
M&E activities.
Lack of synchronisation between sectoral and pro-
grammatic planning cycles, and timeframes for con-
ducting reviews and assessments, pose another
challenge. Murray and Frenk [23] argue that coverage of
public health programmes is an instrumental goal in it-
self that needs to be captured in the overall assessment
of the health systems performance. In addressing this
challenge, interventions are needed at both the global
and national level. At the global level, actors need to
commit to aligning their support to country strategies
and planning cycles; while at the country level, strength-
ened MoH leadership would facilitate ensuring align-
ment of programme and sector strategic planning and
implementation timeframes.
The inadequate time to undertake comprehensive
and good quality performance assessments, as pointed
out by the participants in the meeting, has also been
highlighted by other scholars. Adam et al. [24] high-
light inadequate timeframes, limited capacity and cost
considerations as barriers to undertaking comprehen-
sive assessments. Time constraints may be mitigated
by improved access to data through strengthened rou-
tine health information systems [25], and more regu-
larised partnerships with other government agencies
collected data that is useful for assessing health sector
performance.
Quite often, some recommendations for action from
sector reviews remain unimplemented, especially if there
is inadequate buy-in from the policy and decision
makers. To get more recommendations implemented,
closer interactive knowledge translation processes like
policy dialogue, as highlighted by Panisset et al. [26],
should be promoted. One way to do this is to set up
knowledge translation platforms in countries to system-
atically use evidence in policymaking, a process that has
already started in some of the countries [27].
The lack of effective participation of all health actors
in data generation and use was also highlighted as a
major issue. For instance, the exclusion of the private
sector in sectoral M&E processes is a major gap, espe-
cially in some countries where the patronage of private
health services is increasing. There are examples, how-
ever, of innovation in this regard. For example, in India,
the provision of subsidies and capacity building resulted
in increased reporting from private providers for tuber-
culosis services [28]. However, Lewin and Kaddar [29]
caution that the weak regulatory capacity of government
in low-income countries make scale-up of such models
risky. The private-for-profit sector is a significant player
in health service provision and efforts need to be made
to streamline and enforce the collection and use of data
through the routine health information systems. One op-
tion to address such issues would be to agree on a basic
set of indicators that private-for-profit-providers could
report on routinely.
There also exist political challenges in strengthening
performance assessments for policy dialogue processes.
This partly relates to improving multi-sectoral involve-
ment in health sector annual reviews and evaluations; it
also includes involvement of politicians. Blas et al. [30]
highlight the fact that different viewpoints and under-
standings among stakeholders present a barrier to mov-
ing from rhetoric to action. Targeted dissemination
using multiple channels has proven successful in allow-
ing for focussed and clear messages to different audi-
ences to stimulate action [31]. Blas et al. [30] reported
similar findings, where some stakeholders took no action
based on the evidence provided because they felt that
the required action was outside their mandate and areas
of influence. One option in addressing this challenge is
seeking closer involvement of politicians through the en-
tire process of analysing and interpreting data as op-
posed to sharing results at the very end. This has been
shown to be beneficial in several ways, in that they
understand the genesis of the recommendations, have
more trust in the data and have been part of the process
[32]. Jacobson et al. [33] developed a knowledge transla-
tion framework consisting of five domains: the user
Nabyonga-Orem et al. Health Research Policy and Systems  (2016) 14:87 Page 6 of 8
group, the issue, the research, the knowledge translation
relationship, and dissemination strategies, with an em-
phasis on understanding the context of the user. Shroff
et al. [34] recognise the critical importance of contextual
and political factors and therefore advocate for consider-
ation of leadership as an additional domain influencing
the evidence-to-policy process for Jacobson’s framework
to apply to low-income settings.
The totality of this reflection raises the question of
whether it is possible or even desirable for country
M&E plans to be standardised and harmonised. There
are several inherent conflicts here. First, is the long-
standing tension between standardisation, uniformity
and control versus creativity, adaptation and organisa-
tional learning – top-down frameworks intrinsically
work against the generative, organic quality of bottom-
up processes [35, 36]. Furthermore, evidence has shown
that the medium-term expenditure framework, which is
designed to support operational planning and budget-
ing, in fact created challenges in its standardising ap-
proach. In a multi-country study of several sub-Saharan
countries, Le Houerou and Talierco [37] found mis-
alignments between higher-level resource allocation
(e.g. at the level of the Ministry of Finance) and sectoral
budgets, further complicating the difficulties of plan-
ning timeframes. Secondly, given the involvement of
donor partners in programme funding and its influence
on country M&E processes, it highlights the challenges
of ill-defined harmonisation between donor procedures
and country MoH procedures, which further leads to
suboptimal local ownership [38]. However, we caution
that, while the illustration of standardising within the
medium-term expenditure framework is helpful, it is a
fundamentally different process from standardising per-
formance assessment.
Conclusion
The question of what M&E is for in a country must
be asked and answered clearly if the utility of these
processes is to be maximised for informing policy dia-
logue and improving health sector performance.
While it may be challenging and not always ideal to
standardise planning and policy development pro-
cesses for many reasons, among which is the shifting
politics and donor funding cycles, arguments exist as
to why standardising performance assessment is of
great importance. It enables assessing performance
over time and whether strategic plan objectives and
policy aspirations are being met. Furthermore, it al-
lows for comparisons across countries and subna-
tional entities providing room for cross learning and
replication of good lessons.
Identified challenges to standardising programmes and
the health sector need to be overcome. There is a need
for strengthened MoH leadership to ensure aligned
health sector and programme strategies and plans, as
well as responsive investments of donor funds in health
information systems and skills building. Global efforts in
this perspective, specifically the Health Data Collabora-
tive initiative, which seeks to improve collective action
to maximise the impact of the different partners’ invest-
ments in country health information systems, need to be
exploited. Effective involvement of stakeholders right
from data generation will increase ownership and confi-
dence in the evidence and subsequently its use in policy
dialogue and decision making. Follow-up mechanisms
need to be instituted to ensure that findings from re-
views inform action, are adaptively managed and ensure
continued learning. In addition, health sector perform-
ance assessments need to be institutionalised as part of
the accountability mechanism, must be planned for and
the funding secured within annual budget and medium-
term expenditure frameworks.
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